10-Q: One World Products Swings to Profit on Eco Bio Acquisition

Sentiment:

Quarterly Report


One World Products, Inc. reported a significant net income for Q3 2025, driven by a bargain purchase gain from the Eco Bio Plastics Midland acquisition, despite ongoing liquidity concerns.

Capital raiseThe company explicitly states it "may need to raise additional cash to fund our operations" for the next twelve months.Management will "seek additional financing" if sales do not materialize at expected rates.The ability to scale production and distribution is "largely dependent on our success in raising additional capital."The company has an existing Equity Line of Credit (ELOC) Purchase Agreement with Tysadco Partners, LLC for up to $10,000,000 of common stock, though no advances have been made to date.The company has issued numerous unsecured promissory notes to related parties, including Dr. John McCabe and Isiah L. Thomas, III, totaling $1,135,000 in proceeds from notes payable to related parties during the nine months ended September 30, 2025.
Better than expectedThe company reported a net income of $5.27 million for the three months ended September 30, 2025, a significant improvement from a net loss of $0.73 million in the same period last year.For the nine months ended September 30, 2025, the company achieved a net income of $4.74 million, compared to a net loss of $3.30 million in the prior year.Revenue increased by 3,194% for the quarter and 1,591% for the nine-month period, primarily due to the acquisition of Eco Bio Plastics Midland, Inc.The significant positive results are largely attributable to a $6.05 million bargain purchase gain recognized from the Eco Bio Plastics acquisition.

Summary

  • Net income of $5.27 million for the three months ended September 30, 2025, a substantial improvement from a $0.73 million loss in the prior year period.
  • For the nine months ended September 30, 2025, net income was $4.74 million, compared to a $3.30 million loss in the same period last year.
  • Revenue increased by 3,194% to $49,966 for the three months and 1,591% to $51,619 for the nine months ended September 30, 2025, primarily due to Eco Bio Plastics product sales.
  • The company acquired Eco Bio Plastics Midland, Inc. assets on July 14, 2025, for $415,000 cash, resulting in a $6.05 million bargain purchase gain.
  • Cash on hand increased to $168,620 as of September 30, 2025, from $42,456 at December 31, 2024.
  • The company faces substantial doubt about its ability to continue as a going concern due to negative working capital of $3.95 million and an accumulated deficit of $26.12 million.
  • The Board of Directors and majority shareholder approved a name change to Isiah Enterprises, Inc. and an increase in authorized common stock to 1 billion shares.

Sentiment

Score: 6

Explanation: While the company reported a significant net income driven by a bargain purchase gain and substantial revenue growth from the acquisition, the persistent 'going concern' warning, negative working capital, and reliance on related party financing temper the overall positive sentiment. The strategic shift to green manufacturing is promising, but execution and further capital raises are critical.

Positives

  • Achieved net income of $5.27 million for the three months ended September 30, 2025, a significant turnaround from a $0.73 million net loss in the prior year.
  • Reported net income of $4.74 million for the nine months ended September 30, 2025, compared to a $3.30 million net loss in the same period last year.
  • Revenue surged by 3,194% to $49,966 for the three months and 1,591% to $51,619 for the nine months ended September 30, 2025, driven by the Eco Bio Plastics acquisition.
  • Realized a $6.05 million bargain purchase gain from the acquisition of Eco Bio Plastics Midland, Inc. assets.
  • Operating loss significantly improved for the nine months, decreasing by 55% from $(1,522,343) in 2024 to $(681,770) in 2025.
  • Cash balance increased by 297% to $168,620 as of September 30, 2025, from $42,456 at December 31, 2024.
  • Accumulated deficit reduced from $(30,864,698) at December 31, 2024, to $(26,120,538) at September 30, 2025.

Negatives

  • Substantial doubt exists about the company's ability to continue as a going concern due to insufficient funds to sustain operations for the next twelve months.
  • Negative working capital worsened to $(3,953,402) as of September 30, 2025, from $(3,100,289) at December 31, 2024.
  • Disclosure controls and procedures were not effective as of September 30, 2025, although a specific misclassification was remediated.
  • Significant reliance on related party debt financing, with $3,301,175 in total notes payable to related parties as of September 30, 2025.
  • The company is still in an early development stage, making future revenue levels difficult to project.

Risks

  • Substantial doubt about the company's ability to continue as a going concern due to negative working capital, accumulated deficit, and the need for additional financing.
  • Inability to generate sufficient funds to sustain operations for the next twelve months.
  • Dependence on raising additional capital to scale production, distribution, and increase brand value.
  • Disclosure controls and procedures were not effective as of September 30, 2025, indicating potential weaknesses in financial reporting.
  • Reliance on related party debt, which could introduce conflicts of interest or specific repayment pressures.
  • The company is a smaller reporting company and is not required to provide certain risk factor disclosures, which may limit investor insight.

Future Outlook

The company is in an early development stage and cannot project future revenue levels. Its ability to scale production and distribution capabilities and increase brand value is largely dependent on successfully raising additional capital. The approved name change to Isiah Enterprises, Inc. and increased authorized common stock are strategic moves for future growth, pending regulatory approval.

Management Comments

  • We are too early in our development stage to project future revenue levels and may not be able to generate sufficient funds to sustain our operations for the next twelve months.
  • In the event sales do not materialize at the expected rates, management will seek additional financing and would attempt to conserve cash by further reducing expenses.
  • Our ability to scale production and distribution capabilities and further increase the value of our brands is largely dependent on our success in raising additional capital.
  • Management has implemented enhanced review procedures over acquisition accounting and financial statement classification.

Industry Context

The acquisition of Eco Bio Plastics Midland, Inc. positions the company in the rapidly growing market for sustainable materials and green manufacturing. This move aligns with global demand for ESG-compliant alternatives to traditional materials, particularly in the automotive, food, and industrial sectors. Eco Bio Plastics' advanced micronization and pelletization process for biofibers from organic matter addresses the industry's need for recyclable, lightweight, and high-performance solutions.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Operating Officer (EBPIE, LLC)NAFukuji Saotome2024-07-11New executive employment agreement following the Eco Bio Plastics acquisition.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Corporate Name ChangeBoard of Directors and majority shareholder approved changing the company's corporate name to Isiah Enterprises, Inc., pending FINRA approval.2025-07-28A rebranding effort to align with new strategic direction, potentially enhancing market perception and investor appeal.
Authorized Common Stock IncreaseBoard of Directors and majority shareholder approved increasing the number of authorized shares of common stock from 250,000,000 to 1,000,000,000 shares.2025-07-28Provides greater flexibility for future equity financing, stock-based compensation, and potential acquisitions, but also risks dilution for existing shareholders.

Legal Proceedings

  • The company is not a party to any legal or administrative proceedings that are believed to have a material adverse effect on its financial condition or results of operations.
  • The Colombian subsidiary, One World Pharma S.A.S. (OWP Colombia), entered into a liquidation proceeding effective October 1, 2024, under Colombian Law 1116 of 2006. This is not expected to have a significant impact on the company's financial statements as operations were previously deconsolidated.

Related Party Transactions

  • Received $150,000 from Dr. John McCabe (significant shareholder) in September 2025 for a promissory note at 10% interest.
  • Received $150,000 from Dr. John McCabe (significant shareholder) in August 2025 for a promissory note at 10% interest.
  • Received $415,000 from Isiah Lord Thomas III (significant shareholder, officer, Chairman) in July 2025 for a secured promissory note at 10% interest, secured by acquired property.
  • Received $400,000 from Dr. John McCabe (significant shareholder) in April 2025 for a promissory note at 10% interest.
  • Received $20,000 advance from Isiah L. Thomas, III (Chairman & CEO) in April and March 2025 for an unsecured promissory note at 10% interest.
  • Issued 882,353 shares of common stock to the CFO on June 25, 2025, with a fair value of $15,000.
  • Issued 694,445 shares of common stock to the CFO on March 25, 2025, with a fair value of $15,000.
  • Total amount due to one of the company's directors was $27,977 at September 30, 2025.
  • Various unsecured promissory notes issued to Dr. John McCabe, Isiah L. Thomas, III, Dr. Kenneth Perego, II, M.D., and Joerg Sommer in 2024 and 2025, totaling $3,301,175 in principal as of September 30, 2025.

Stakeholder Impact

  • Shareholders: Potential for significant dilution due to the increase in authorized common stock and ongoing need for capital raises. The net income is positive, but the going concern warning remains a major risk.
  • Employees: New COO appointed for Eco Bio Plastics, indicating growth in that segment. Salaries, wages, and benefits are now a significant operating expense.
  • Customers: The acquisition of Eco Bio Plastics aims to offer cost-effective, ESG-compliant, sustainable material alternatives, potentially benefiting automotive, food, and industrial clients.
  • Creditors: Related party creditors are providing significant financing, but the going concern warning indicates elevated risk for all creditors.

Next Steps

  • FINRA approval for the corporate name change to Isiah Enterprises, Inc.
  • Increase in authorized common stock to 1,000,000,000 shares, expected on or before November 1, 2025.
  • Management will seek additional financing and attempt to conserve cash if sales do not meet expectations.
  • Scaling production and distribution capabilities for Eco Bio Plastics products.
  • Continued assessment of the effect of new accounting pronouncements (ASU 2024-03, ASU 2025-01) on financial statements.

Key Dates

DateDescription
2014-09-02Company incorporated in Nevada.
2019-02-21Entered into Agreement and Plan of Merger with OWP Merger Subsidiary, Inc. and OWP Ventures, Inc.
2020-02-12Company's stockholders approved the 2019 Stock Incentive Plan.
2022-09-01Entered into an Equity Line of Credit (ELOC) Purchase Agreement with Tysadco Partners, LLC for up to $10,000,000 of common stock.
2023-08-18OWP Ventures, Inc. issued an unsecured promissory note of $35,000 to LDL8 Consulting LLC.
2023-12-22Colombian subsidiary, One World Pharma S.A.S. (OWP Colombia), filed for reorganization proceedings.
2024-03-15Issued unsecured promissory notes to Joerg Sommer, Dr. John McCabe, Dr. Kenneth Perego, II, M.D., and Isiah L. Thomas, III.
2024-03-19Received an advance of $50,000 from Joerg Sommer.
2024-03-24Issued an unsecured promissory note of $10,000 to Isiah L. Thomas, III.
2024-04-02Issued an unsecured promissory note of $10,000 to Isiah L. Thomas, III.
2024-04-07Issued an unsecured promissory note of $50,000 to John McCabe.
2024-04-19Completed sale of a $1,300,000 promissory note to SDT Equities LLC and a $300,000 promissory note to AJB Capital Investments LLC.
2024-04-21Issued an unsecured promissory note of $250,000 to John McCabe.
2024-07-11EBPIE entered into an Executive Employment Agreement with Fukuji Saotome as COO; Company granted Fukuji Saotome an option to purchase 5,000,000 shares.
2024-07-14Company completed the acquisition of assets of Eco Bio Plastics Midland, Inc.
2024-07-15Issued a secured promissory note of $415,000 to Isiah Lord Thomas III.
2024-07-26Repaid $150,000 principal on a promissory note to Dr. Kenneth Perego, II, M.D.
2024-07-28Majority shareholder approved an increase in authorized common stock to 1,000,000,000 shares and a name change to Isiah Enterprises, Inc.
2024-08-04Received an advance of $60,000 from Dr. John McCabe.
2024-08-18Issued an unsecured promissory note of $90,000 to Dr. John McCabe.
2024-09-12Issued an unsecured promissory note of $150,000 to Dr. John McCabe.
2024-09-16Convertible note payable, related party, matured and was repaid.
2024-09-30End of the current reporting period for the 10-Q.
2024-10-01Colombian subsidiary, One World Pharma S.A.S. (OWP Colombia), entered into a liquidation proceeding.
2024-10-15Authorized common stock amended to 1,000,000,000 shares.
2024-11-01Expected date for the increase in authorized common stock to occur.
2024-11-29Received an advance of $24,195 from Dr. Kenneth Perego, II, M.D.
2024-12-16Issued unsecured promissory notes to Isiah L. Thomas, III and Dr. Kenneth Perego, II, M.D.
2024-12-26Issued an unsecured promissory note of $30,000 to Dr. John McCabe.
2024-12-31End of the previous fiscal year for comparison.
2025-01-02Number of common stock shares outstanding was 120,108,774.
2025-03-25Issued 694,445 shares of common stock to the CFO.
2025-06-25Issued 882,353 shares of common stock to the CFO.
2025-07-11Company, EBPIE, LLC, and Eco Bio signed and closed an Asset Purchase Agreement.
2025-07-3120% of Fukuji Saotome's stock option vested.
2025-08-04Received an advance of $60,000 from Dr. John McCabe.
2025-08-18Issued an unsecured promissory note of $90,000 to Dr. John McCabe.
2025-09-12Issued an unsecured promissory note of $150,000 to Dr. John McCabe.
2025-09-30End of the current reporting period for the 10-Q.
2025-12-23Fukuji Saotome's stock option vests 20%.
2025-12-27Fukuji Saotome's stock option vests 20%.
2025-12-28Fukuji Saotome's stock option vests 20%.
2025-12-29Fukuji Saotome's stock option vests 20%.
2025-12-30Fukuji Saotome's stock option vests 20% and expires.
2026-12-15Effective date for ASU 2024-03 and ASU 2025-01 (Expense Disaggregation Disclosures) for annual reporting periods.
2027-12-15Effective date for ASU 2024-03 and ASU 2025-01 (Expense Disaggregation Disclosures) for interim reporting periods.
2029-12-102019 Stock Incentive Plan terminates.
2030-12-31Fukuji Saotome's stock option expires.

Recommendation

hold

While the company reported a substantial net income and revenue growth driven by the Eco Bio Plastics acquisition and its associated bargain purchase gain, the underlying financial health remains precarious. The 'going concern' warning, significant negative working capital, and heavy reliance on related party debt indicate high operational and financial risk. The strategic shift to green manufacturing and the planned name change are positive long-term signals, but the immediate future depends heavily on successful capital raises and sustained operational improvements. Investors should hold, closely monitoring liquidity, operational execution, and future financing activities before considering further investment.

Keywords

Eco Bio Plastics, Bargain Purchase Gain, Sustainable Materials, Green Manufacturing, Biofibers, Pelletized Bast Fiber, Going Concern, SEC 10-Q, Isiah Enterprises, Corporate Name Change, Authorized Shares Increase, Related Party Debt, Financial Turnaround, Nevada Corporation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.